pRK5-myc-PRAS40 Citations (3)

Originally described in: Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH Nat Cell Biol. 2007 Mar . 9(3):316-23. PubMed Journal

---

Articles Citing pRK5-myc-PRAS40

Articles
PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways. Lv D, Liu J, Guo L, Wu D, Matsumoto K, Huang L. Am J Cancer Res. 2016 Jan 15;6(2):486-97. eCollection 2016. PubMed
mTORC1 induces eukaryotic translation initiation factor 4E interaction with TOS-S6 kinase 1 and its activation. Majeed ST, Batool A, Majeed R, Bhat NN, Zargar MA, Andrabi KI. Cell Cycle. 2021 May;20(9):839-854. doi: 10.1080/15384101.2021.1901038. Epub 2021 May 3. PubMed
PGK1 represses autophagy-mediated cell death to promote the proliferation of liver cancer cells by phosphorylating PRAS40. Zhang T, Wang Y, Yu H, Zhang T, Guo L, Xu J, Wei X, Wang N, Wu Y, Wang X, Huang L. Cell Death Dis. 2022 Jan 20;13(1):68. doi: 10.1038/s41419-022-04499-0. PubMed

If you have published an article using this material, please email us at to have your article added to this page.